These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22811416)

  • 1. Emerging role of multimodality imaging to evaluate patients at risk for sudden cardiac death.
    Bertini M; Schalij MJ; Bax JJ; Delgado V
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):525-35. PubMed ID: 22811416
    [No Abstract]   [Full Text] [Related]  

  • 2. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
    Saba S
    Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary prevention of sudden death--afraid of the truth].
    Meyer FP
    Dtsch Med Wochenschr; 2003 Mar; 128(10):514; author reply 514. PubMed ID: 12627348
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden death due to cardiac arrhythmias.
    Huikuri HV; Castellanos A; Myerburg RJ
    N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
    Talajic M; Mitchell LB; Hadjis T
    Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary prevention of sudden death - afraid of the truth].
    Klein H
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantation of cardiac defibrillators for primary prevention: a pendulum too far?
    Ferreira SW; Hauptman PJ
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1047-50. PubMed ID: 18793106
    [No Abstract]   [Full Text] [Related]  

  • 12. Sudden cardiac arrest and sudden cardiac death on dialysis: Epidemiology, evaluation, treatment, and prevention.
    Alpert MA
    Hemodial Int; 2011 Oct; 15 Suppl 1():S22-9. PubMed ID: 22093597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP
    Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation.
    Mehta D; Mori N; Goldbarg SH; Lubitz S; Wisnivesky JP; Teirstein A
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):43-8. PubMed ID: 21193539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiologic assessment of surviving family members of young victims of sudden cardiac death: diagnostic yield].
    Autore C; Pagannone E; Re F; Romeo D; Musumeci B; Baratta P; Marino L; Cauti FM; Zachara E
    G Ital Cardiol (Rome); 2010; 11(7-8):557-65. PubMed ID: 21033332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICD for primary prophylaxis of sudden cardiac death: an Indian perspective.
    Naik N; Juneja R
    J Assoc Physicians India; 2007 Apr; 55 Suppl():47-53. PubMed ID: 18376491
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.